Evidence map›Paper›PMID 31350231›Full record

ArticleBMJ case reports2019

'Enemy within': an interesting cause for anemia during warfarin therapy for atrial fibrillation.

Anita Ann Sunny, Josy Vallipalam, Balakrishnan Ramasamy, Rajesh Shankar Iyer

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Anita Ann SunnyNeurology, PSG Institute of Medical Sciences and Research, Coimbatore, India.
Josy VallipalamNeurology, PSG Institute of Medical Sciences and Research, Coimbatore, India.
Balakrishnan RamasamyNeurology, PSG Institute of Medical Sciences and Research, Coimbatore, India.
Rajesh Shankar IyerNeurology, PSG Institute of Medical Sciences and Research, Coimbatore, India.
PSG Institute of Medical Sciences & Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The oral anticoagulant warfarin is a vitamin K antagonist and is considered the first line anticoagulant in valvular atrial fibrillation. However prothrombin time should be closely monitored, drug interactions checked and compliance regarding diet ensured when the patient is on warfarin therapy. Anaemia should be looked for, evaluated for the cause and corrected since it is an independent predictor of bleeding and thrombotic episodes during warfarin therapy for atrial fibrillation We present an interesting case of anaemia which developed during warfarin therapy for atrial fibrillation. The patient was on amiodarone and was consuming leafy vegetables resulting in frequent raise in prothrombin time during which time she developed bleeding into the right femoral pseudoaneurysm which had developed following catheterisation for thrombectomy. Surgical correction of pseudoaneurysm was done, comedication was changed and diet compliance ensured which resulted in the subsequent maintenance of prothrombin time in the therapeutic range and steady haemoglobin levels.

Indexed as

AnemiaAneurysm, FalseAnticoagulantsAtrial FibrillationCardiac CatheterizationDirective CounselingFemaleHumansMiddle AgedProthrombin TimeSpinacia oleraceaTreatment OutcomeVitamin KWarfarinAnticoagulantsVitamin KWarfarindrug interactionswarfarin therapy

Identifiers

PMID31350231
PMCPMC6663219
OpenAlexW2965188268

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.